Register for SOSV Deep Tech Live – Dr. Rick Gottscho on Plasma & Semiconductors

Neurocarrus Inc

Developing long acting non-opioid chronic pain medications

Company details

Neurocarrus is a biotechnology company developing a novel drug delivery technology to safely disrupt pain signals without addiction-forming medications or disruption of muscular control.

More than 11 million people abused prescription opioids in 2016, and the CDC estimates it has an economic cost of $80B a year

Neurocarrus Inc Quote Image
Benjamin Pavlik, PhD, CEO
Our success as a company would change the healthcare industry by providing an alternative to opioids as a front-line pain management solution.

Team

Paul Blum

CEO and Co-Founder

Get In Touch with Neurocarrus Inc

Please tell us a little bit about yourself and why you'd like to get connected. Neurocarrus Inc + SOSV will follow up with you via email.

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.